Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A phase II study of laquinimod in Crohn's disease.
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Laquinimod - New Promising Treatment for Multiple Sclerosis
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.
Metabolic features of the cell danger response.
Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with MS.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier.
Video game training enhances cognitive control in older adults.
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Vivitrol dosing and administration
Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.
Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
Function and distribution of three types of rectifying channel in rat spinal root myelinated axons.
Pages
« first
‹ previous
…
103
104
105
106
107
108
109
110
111
…
next ›
last »